Pristiq: new antidepressantWyeth is introducing Pristiq (desvenlafaxine 50 mg and 100 mg extended-release tablets) for the symptomatic relief of major depressive disorder in adults. CFP announces new presidentPeter Marshall has been appointed president of the Canadian Foundation for Pharmacy for 2009. Lax-A-Day: new PEG oral laxative PendoPharm/Pharmascience is introducing a new OTC osmotic laxative, Lax-A-Day (polyethylene glycol [PEG] 3350 powder for oral solution). New indication for Aclasta Novartis' Aclasta (zoledronic acid injection) is now approved for use as a once-yearly intravenous (IV) infusion in the prevention and treatment of corticosteroid-induced osteoporosis, to increase bone mineral density. Universal hepatitis A vaccine may be warranted Despite travel and other risks, study of Nova Scotia students finds vaccine recommendations not followed, possibly due to cost Clinical in Brief: Incidental findings common in cervical spine CTs Medicine's power to transform PENSIONS: The European experience Don't let terminal diagnosis end patient communicaiton Ontario looking at wider non-physician prescribing Will examine scopes of practice for allied health professionals First Previous 3816 3817 3818 3819 3820 Next Last
